Eevia Health Plc, (”Eevia” or ”The Company”), has received a 43,3 KEUR sales order from the US for Fenoprolic 70 Organic, an organically certified pine bark extract
The end customer is a large supplement brand holder which operates in several channels in North America and in Europe. The immediate customer is Barrington Nutritionals, a US distributor.
The sales value to Eevia of this new order is c. 43,3 kEUR. The product is Eevia’s branded ingredient Fenoprolic® 70 Organic, which is a highly concentrated and organically certified pine bark extract.
The product contains 70% oligomeric proanthocyanidins and offers clinical benefits for people with osteoarthritis and chronic inflammation. It is extracted and standardized from bark originating from the Pinus Sylvestris pine trees that are abundant in Finland and Sweden.
“Eevia is particularly happy to receive orders for the Fenoprolic® 70 Organic, because it is the product with best profitability of our product lines and there are significant sales opportunities for this product.” states Stein Ulve, CEO.
The order is expected to be followed by further repeat orders in the future.